And this works for metastatic lymph nodes also.

Sentinel lymph node dissection has really changed the way that we manage breast cancer, melanoma.

He took women with metastatic breast cancer, randomly divided them into two groups.

Yet when it came to a disease like diabetes that kills Americans eight times more frequently than melanoma,

I have a reoccurrence of stage 3 metastatic breast cancer, so what are the odds I'll be here...

In 1941, Charles B. Huggins published studies in which he used estrogen to oppose testosterone production in men with metastatic prostate cancer.

Excluding non melanoma skin cancers, there were 88,398 new cancer cases (337.6 per 100,000 ) and 36,319 deaths due to cancer in Australia (127.3 per 100,000 ) in 2001.

Target settings with a low or very low burden of disease it is clear that vaccines will not work in patients with advanced metastatic disease.

Sipuleucel T, a cancer vaccine has been found to result in a benefit (a four month increase in survival) for men with metastatic prostate cancer.

Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.

If I give a woman with breast cancer a drug called Taxol every three weeks, which is the standard, about 40 percent of women with metastatic cancer have a great response to that drug.

If I give a woman with breast cancer a drug called Taxol every three weeks, which is the standard, about 40 percent of women with metastatic cancer have a great response to that drug.

I was also doing cancer research, immune based therapies for melanoma, to be specific, and in that world I was actually taught to question everything, to challenge all assumptions and hold them to the highest possible scientific standards.

In females, breast cancer (11,791 cases, or 93.1 per 100,000 population ) is the most common registrable cancer, followed by colorectal cancer (5,883), melanoma (3,861) and lung cancer (2,891), in total, they account for 60 per cent of all registrable cancers in females.

I won't go into this very much, but our technology, besides being able to tag tumor and metastatic lymph nodes with fluorescence, we can also use the same smart three part molecule to tag gadolinium onto the system so you can do this noninvasively.

Follow up Follow up is necessary in all women with gestational trophoblastic disease, because of the possibility of persistent disease, or because of the risk of developing malignant uterine invasion or malignant metastatic disease even after treatment in some women with certain risk factors.

I won't go into this very much, but our technology, besides being able to tag tumor and metastatic lymph nodes with fluorescence, we can also use the same smart three part molecule to tag gadolinium onto the system so you can do this noninvasively.